Catherine Sazdanoff and John McIlwraith have been elected independent directors to Meridian Biosciences' board, effective Aug. 14.
Sazdanoff is the CEO and president of Sazdanoff Consulting. Between 2006 and 2015, she held various executive positions at Takeda Pharmaceutical International, including vice president, head of corporate projects; VP global business development; and VP corporate development. Prior to Takeda, Sazdanoff spent 22 years at Abbott Laboratories.
McIlwraith co-founded venture capital firm Allos Ventures in 2010 and has been a managing director there since then. Prior to that, he was a managing director at Blue Chip Venture. He currently is the lead director at Assurex Health.